Pharmaceuticals Manufacturing
- All
- News
- Videos
-
Madhya Pradesh Doctor Who Prescribed Deadly Cough Syrup To Children Arrested
The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, the company that manufactured the Coldrif syrup.
-
Cough Syrup Kills 2 Children In Rajasthan; Doctor Takes It To Prove It's Safe And Faints
A generic cough syrup manufactured by a pharmaceutical company for the Rajasthan government has led to the deaths of two children and at least 10 others falling ill in the state over the past two weeks, officials said.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Donald Trump Plans To Impose New Tariffs "Over Next Month". What's On Target
US President Donald Trump is planning to announce tariffs on more products as he pushes to shrink America's trade deficits, boost domestic manufacturing and achieve other policy goals.
-
India's Manufacturing Incentives Progress Amid Efforts to Cut China Imports
Since 2020, India's cash incentives to boost domestic manufacturing have attracted over $17 billion (roughly Rs. 1,42,279 crore) of investment. The scheme, which offers four to six percent cash incentives on incremental sales to manufacturers, was launched across 14 sectors including electronics, pharmaceuticals, textiles and white goods.
-
AstraZeneca To Build $1.5 Billion Cancer Drug Facility In Singapore
British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.
-
New Drug-Making Standards For Indian Pharma Firms After Overseas Deaths
Indian pharmaceutical companies must meet new manufacturing standards this year, according to a government notification released on Saturday, although small companies have asked for a delay, citing their debt load.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Rising Cybersecurity Attacks Highlight Vulnerabilities of Indian Companies as They Digitise Operations
A rise in cyberattacks poses a vital risk to India’s economic ambitions, with industries from manufacturing to pharmaceuticals becoming more vulnerable as they digitise operations, according to Google Cloud. Attacks have spiked significantly in the past six months, said Amit Pradhan, India consulting leader for the cybersecurity firm Mandiant.
-
New Drug Export Policy Likely After Concerns On India-Made Drugs: Sources
The Union Health Ministry and the Department of Pharmaceuticals are deliberating this new policy, ministry sources said. Suggestions were sought from the Directorate General of Foreign Trade (DGFT) regarding this.
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Uzbekistan Syrup Deaths: Noida Firm's Licence Cancelled By Uttar Pradesh
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials.
-
Uzbekistan Child Deaths: 3 Employees Of Noida-Syrup Manufacturer Arrested
Cough Syrup Deaths: The Noida Police on Friday arrested three employees of a city-based pharmaceutical firm whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, officials said.
-
Madhya Pradesh Doctor Who Prescribed Deadly Cough Syrup To Children Arrested
The Madhya Pradesh government also filed a case against Srisan Pharmaceuticals, the company that manufactured the Coldrif syrup.
-
Cough Syrup Kills 2 Children In Rajasthan; Doctor Takes It To Prove It's Safe And Faints
A generic cough syrup manufactured by a pharmaceutical company for the Rajasthan government has led to the deaths of two children and at least 10 others falling ill in the state over the past two weeks, officials said.
-
Countries And Companies Threatened By Trump's 100% Tariffs On Pharma
Donald Trump has shocked the global drug industry by announcing 100-percent tariffs on all branded, imported pharmaceutical products -- unless companies are building manufacturing plants in the United States.
-
Why Trump's 100% Pharma Tariffs May Not Impact Indian Drugmakers Much
US President Donald Trump has said his administration will impose 100 per cent import tariffs on branded or patented pharmaceutical drugs from October 1, unless the pharma companies have or are building their manufacturing units in America.
-
Trump Declares 100% Tariff On Pharma Imports From October 1, India May Be Hit
US President Donald Trump has announced tariffs of up to 100 per cent on imports of branded and patented pharmaceutical products from October 1. India's pharmaceuticals sector, one of the most dependent domestic industries on trade with America.
-
Donald Trump Plans To Impose New Tariffs "Over Next Month". What's On Target
US President Donald Trump is planning to announce tariffs on more products as he pushes to shrink America's trade deficits, boost domestic manufacturing and achieve other policy goals.
-
India's Manufacturing Incentives Progress Amid Efforts to Cut China Imports
Since 2020, India's cash incentives to boost domestic manufacturing have attracted over $17 billion (roughly Rs. 1,42,279 crore) of investment. The scheme, which offers four to six percent cash incentives on incremental sales to manufacturers, was launched across 14 sectors including electronics, pharmaceuticals, textiles and white goods.
-
AstraZeneca To Build $1.5 Billion Cancer Drug Facility In Singapore
British pharmaceutical giant AstraZeneca said Monday that it planned to build a $1.5 billion plant in Singapore to manufacture next-generation drugs to treat cancer.
-
New Drug-Making Standards For Indian Pharma Firms After Overseas Deaths
Indian pharmaceutical companies must meet new manufacturing standards this year, according to a government notification released on Saturday, although small companies have asked for a delay, citing their debt load.
-
Glenmark Pharmaceuticals Recalls 1,200 Bottles Of "Subpotent" Hypertension Drug In US
Glenmark Pharmaceuticals is recalling 1,200 bottles of a generic drug, used to treat high blood pressure, in the American market due to a manufacturing issue, according to the US Food and Drug Administration (USFDA).
-
Rising Cybersecurity Attacks Highlight Vulnerabilities of Indian Companies as They Digitise Operations
A rise in cyberattacks poses a vital risk to India’s economic ambitions, with industries from manufacturing to pharmaceuticals becoming more vulnerable as they digitise operations, according to Google Cloud. Attacks have spiked significantly in the past six months, said Amit Pradhan, India consulting leader for the cybersecurity firm Mandiant.
-
New Drug Export Policy Likely After Concerns On India-Made Drugs: Sources
The Union Health Ministry and the Department of Pharmaceuticals are deliberating this new policy, ministry sources said. Suggestions were sought from the Directorate General of Foreign Trade (DGFT) regarding this.
-
Gujarat Pharma Firm Recalls Over 55,000 Medicine Bottles From US Market
The affected lot is manufactured by Ahmedabad-based Zydus Lifesciences and marketed in the US by New Jersey-based Zydus Pharmaceuticals (USA) Inc.
-
Uzbekistan Syrup Deaths: Noida Firm's Licence Cancelled By Uttar Pradesh
The manufacturing licence of Noida-based pharmaceutical firm Marion Biotech was cancelled on Wednesday by Uttar Pradesh authorities, according to officials.
-
Uzbekistan Child Deaths: 3 Employees Of Noida-Syrup Manufacturer Arrested
Cough Syrup Deaths: The Noida Police on Friday arrested three employees of a city-based pharmaceutical firm whose cough syrup is alleged to have led to the death of 18 children in Uzbekistan last year, officials said.
